U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many more doses can't be used and must be thrown out.
U.S. regulators are allowing for the release of 10 million doses of Johnson and Johnson's COVID-19 vaccine from a troubled Baltimore factory. Many batches will be tossed.
WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.
CAPE TOWN, South Africa (AP) — COVID-19 vaccine shipments have ground to “a near halt” in Africa while virus cases have spiked 20% over the last two weeks, the World Health Organization said Thursday, a bleak scenario for the continent on both those critical fronts.
Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.
The FDA has agreed to let adolescents between the ages of 12 and 15 receive the Pfizer COVID-19 vaccine, making it the first available for use in children under 16.
President Joe Biden is setting a new vaccination goal to deliver at least one dose to 70% of adult Americans by July 4. The goal also includes fully vaccinating 160 million adults by then.
America's daily Covid-19 cases and deaths are now about one-fifth of what they were during their winter peaks -- and one expert says the country's improved numbers have a lot to do with the climbing vaccinations.
The US Food and Drug Administration is poised to authorize Pfizer/BioNTech's coronavirus vaccine in children and teens ages 12 to 15 by early next week, a federal government official tells CNN.
U.S. regulators say the Baltimore factory contracted to make Johnson & Johnson’s COVID-19 vaccine was dirty, didn’t follow proper manufacturing procedures and had poorly trained staff.
The first children have been vaccinated in Moderna's Phase 2/3 pediatric Covid-19 vaccine trial, the company announced Tuesday in a statement.
U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday. Formal authorization is expected soon, with distribution coming within days.
Virus update: Johnson & Johnson applied for emergency authorization of its coronavirus vaccine. Plus, the U.S. fell behind in the race to detect dangerous COVID-19 mutations. Here's the latest.
Johnson & Johnson officially asked the Food and Drug Administration for an emergency use authorization of its COVID-19 vaccine Thursday.
Four leading baby food manufacturers sold baby food that contained high levels of toxic heavy metals, a congressional investigation found.
The Food and Drug Administration says it is "rapidly" working toward issuing an emergency use authorization for the Moderna vaccine -- the second Covid-19 vaccine for the US market -- after the FDA's vaccine advisers voted Thursday to recommend it.
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot from Moderna and the National Institutes of Health to be added to the U.S. vaccination campaign.
The US on Wednesday reported record numbers for Covid-19 cases, hospitalizations and deaths, ahead of a key meeting for what could be the country's second Covid-19 vaccine to get the green light.
The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves. Plus, the pace is intensifying as Washington negotiators try to reach agreement on virus relief.
The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.
A U.S. government advisory panel has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. Here's the latest.
CLAIM: The antiparasitic drug ivermectin “has a miraculous effectiveness that obliterates” the transmission of COVID-19 and will prevent people from getting sick.
COVID-19 cases, hospitalizations and deaths are at record-high levels nationwide, and officials expect the U.S. will soon bear the full brunt of another surge of infections fueled by Thanksgiving gatherings.